Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 2711 Million | USD 4000 Million | 4.1% | 2021 |
FrequentlyAsked Questions
The minimally invasive neurosurgery market grows at a significant rate due to frequent increases in the development of the medical field in the neurological department. There has been a constant rise in the geriatric population who seem to have adapted themselves more towards minimally invasive surgery.
According to the Zion Market Research report, the global minimally invasive neurosurgery device market was worth around $2711 million in 2021 and is predicted to grow to around $4000 million by 2028 at a CAGR rate of 4.1% over the forecast period.
North America is a lucrative contributor to the global minimally invasive neurosurgery device market. This is due to the growing cases of neurological disorders in the region. This has also become the most eminent cause of death that many people are inclined towards this surgery. Rapid technological advancement in the medical field with respect to neurological sectors also boosts market growth.
Major players in the global minimally invasive neurosurgery device market are Karl Storz GmbH & Co. KG, Olympus Corporation, Conmed Corporation, Richard Wolf GmbH, Boston Scientific Inc., Integra Lifescience Holdings Corporation, Aesculap Division, Smith & Nephew Plc, Medtronic, NICO Corp.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed